Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Greenstar Biosciences Corp. (C:GSTR)

Business Focus: Alternative Medicine

Sector:  Healthcare Industry:  Pharmaceuticals
See Regulatory Filings on SEDAR
Company Contact
Address: 717-1030, West Georgia Street
Tel: N/A
Website: N/A
Key People
Ralph Olson
Thomas W. Baird
Chief Executive Officer, Director
Gavin Cooper
Chief Financial Officer, Director
Business Overview
GreenStar Biosciences Corp., formerly Bethpage Capital Corp., is a Canada-based company. The Company owns real estate assets, property leases, brands and intellectual property of Cowlitz County Cannabis Cultivation Inc. (Cowlitz). Cowlitz is a cannabis producer and processor located in Washington State. Cowlitz produces flower, dabs, pre-rolls, cannabinoid powder and infused joints under various brand categories, such as Dab Dudes, Hi Guys and Cowlitz Gold.
Financial Overview
For the six months ended 29 February 2020, Greenstar Biosciences Corp revenues increased from C$213K to C$473K. Net loss increased from C$319K to C$1.7M. Revenues reflect License royalties increase from C$95K to C$250K, Lease increase of 89% to C$223K. Higher net loss reflects Advertising increase from C$16K to C$695K (expense), Share-based compensation increase from C$306K to C$682K (expense).
Reporting Currency: Canadian Dollars
Enterprise value: $3.82M as of May 31, 2020
Annual revenue (TTM): $0.83M as of May 31, 2020
EBITDA (TTM): -$2.69M as of May 31, 2020
Net annual income (TTM): -$1.56M as of May 31, 2020
Free cash flow (TTM): -$1.91M as of May 31, 2020
Net Debt Last Fiscal Year: $0.28M as of May 31, 2020
Shares outstanding: 66,713,367 as of Feb 29, 2020
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization